Skip to main content
. 2013 Dec 18;18(3):329–334. doi: 10.1093/icvts/ivt500

Table 2:

Results of multivariate analysis for predictors of AIS in clinical Stage IA lung cancer patients with a part-solid nodule

Variable Odds ratio 95% Confidence interval P-value*
Preceding malignancies 0.16 0.03–0.96 0.04
CTR 4.97 1.26–19.62 0.02
SUVmax 4.32 1.05–17.68 0.04

AIS: adenocarcinoma in situ; CTR: consolidation/tumour ratio; SUV: standardized uptake value.

*P-value in logistic regression analysis.